PharmaJet Overview
- Year Founded
-
2005
- Status
-
Private
- Employees
-
23
- Latest Deal Type
-
2ndary - Private
- Investors
-
17
PharmaJet General Information
Description
Developer of needle-free fluid injection devices designed to deliver vaccines, therapeutics, and drugs without the use of needles. The company offers devices capable of delivering injections into intradermal, subcutaneous, and intramuscular tissues, enabling healthcare providers to administer medications while reducing needlestick injuries, cross-contamination risks, and sharps waste.
Contact Information
Website
www.pharmajet.comCorporate Office
- 400 Corporate Circle
- Suite N
- Golden, CO 80401
- United States
Corporate Office
- 400 Corporate Circle
- Suite N
- Golden, CO 80401
- United States
PharmaJet Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 19. Secondary Transaction - Private | Completed | Generating Revenue | ||||
| 18. Grant | 20-Sep-2022 | Completed | Generating Revenue | |||
| 17. Later Stage VC | 26-Apr-2021 | Completed | Generating Revenue | |||
| 16. Later Stage VC (Series H) | 10-Jun-2020 | Completed | Generating Revenue | |||
| 15. Grant | 17-Mar-2020 | Completed | Generating Revenue | |||
| 14. Later Stage VC (Series G) | 31-Jan-2020 | Completed | Generating Revenue | |||
| 13. Later Stage VC (Series G) | 22-Jan-2019 | Completed | Generating Revenue | |||
| 12. Later Stage VC (Series F) | 20-Apr-2018 | Completed | Generating Revenue | |||
| 11. Later Stage VC (Series E) | 21-Feb-2018 | $6.01M | $35.3M | Completed | Generating Revenue | |
| 10. Accelerator/Incubator | 01-Jun-2017 | $29.3M | Completed | Generating Revenue |
PharmaJet Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series H | ||||||||
| Series G1 | ||||||||
| Series F | ||||||||
| Series E | ||||||||
| Series D1 | ||||||||
| Series D | ||||||||
| Series C2 | ||||||||
| Series C1 | ||||||||
| Series C | 1,171,421 | $0.000010 | $0.28 | $3.5 | $3.5 | 1x | $3.5 | 4.64% |
| Series B1 | 897,620 | $0.000010 | $0.52 | $6.51 | $6.51 | 1x | $6.51 | 3.55% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
PharmaJet Comparisons
Industry
Financing
Details
PharmaJet Competitors (4)
One of PharmaJet’s 4 competitors is Vaxxas, a Venture Capital-Backed company based in Hamilton, Australia.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Vaxxas | Venture Capital-Backed | Hamilton, Australia | ||||
| NanoPass Technologies | Venture Capital-Backed | Nes Ziona, Israel | ||||
| Portal Instruments | Venture Capital-Backed | Cambridge, MA | ||||
| Crossject | Formerly VC-backed | Dijon, France |
PharmaJet Patents
PharmaJet Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2023428116-A1 | Needle-free injector dose setting apparatus and methods | Pending | 02-Feb-2023 | ||
| EP-4658338-A1 | Needle-free injector dose setting apparatus and methods | Pending | 02-Feb-2023 | ||
| US-12642915-B2 | Needle-free injector dose setting apparatus and methods | Active | 02-Feb-2023 | ||
| US-20240261514-A1 | Needle-free injector dose setting apparatus and methods | Active | 02-Feb-2023 | ||
| US-20260273198-A1 | Needle-free injector dose setting apparatus and methods | Pending | 02-Feb-2023 | A61M5/3243 |
PharmaJet Signals
PharmaJet Investors (17)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| National Cancer Institute | Government | |||
| AngelMD | Angel Group | |||
| Cliintel Capital Management Group | Venture Capital | Minority | ||
| Daicel | Corporation | Minority | ||
| Development Innovation Ventures | Impact Investing |
PharmaJet FAQs
-
When was PharmaJet founded?
PharmaJet was founded in 2005.
-
Where is PharmaJet headquartered?
PharmaJet is headquartered in Golden, CO.
-
What is the size of PharmaJet?
PharmaJet has 23 total employees.
-
What industry is PharmaJet in?
PharmaJet’s primary industry is Medical Supplies.
-
Is PharmaJet a private or public company?
PharmaJet is a Private company.
-
What is PharmaJet’s current revenue?
The current revenue for PharmaJet is .
-
How much funding has PharmaJet raised over time?
PharmaJet has raised $74.9M.
-
Who are PharmaJet’s investors?
National Cancer Institute, AngelMD, Cliintel Capital Management Group, Daicel, and Development Innovation Ventures are 5 of 17 investors who have invested in PharmaJet.
-
Who are PharmaJet’s competitors?
Vaxxas, NanoPass Technologies, Portal Instruments, and Crossject are competitors of PharmaJet.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process